Patents by Inventor Rahul KAUSHIK

Rahul KAUSHIK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230048560
    Abstract: The present invention provides stable pharmaceutical compositions of pegylated carfilzomib compounds, methods for preparing the compositions, and uses of the compositions for treating cancer, including hematologic malignancies such as multiple myeloma. The compositions can be stored in frozen form or lyophilized to dry solid form.
    Type: Application
    Filed: December 23, 2021
    Publication date: February 16, 2023
    Inventors: Alona TERAN, William CALLAHAN, Qahera MUNAIM, Rahul KAUSHIK
  • Patent number: 11241502
    Abstract: The present invention provides stable pharmaceutical compositions of pegylated carfilzomib compounds, methods for preparing the compositions, and uses of the compositions for treating cancer, including hematologic malignancies such as multiple myeloma. The compositions can be stored in frozen form or lyophilized to dry solid form.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: February 8, 2022
    Assignee: AMGEN INC.
    Inventors: Alona Teran, William Callahan, Qahera Munaim, Rahul Kaushik
  • Publication number: 20210163531
    Abstract: The invention relates to methods for preparing stable buffered and buffer-free protein compositions. The invention also relates to methods of purifying proteins from one or more impurities.
    Type: Application
    Filed: March 28, 2019
    Publication date: June 3, 2021
    Inventors: William Callahan, Lorenzo Desantiago, Clea Talley, Yael Wexler-Cohen, Jeffrey Abel, Rahul Kaushik, Nitya Mariam Jacob, Carson Tran, Nicole Ball, Monica Goss
  • Publication number: 20190142957
    Abstract: The present invention provides stable pharmaceutical compositions of pegylated carfilzomib compounds, methods for preparing the compositions, and uses of the compositions for treating cancer, including hematologic malignancies such as multiple myeloma. The compositions can be stored in frozen form or lyophilized to dry solid form.
    Type: Application
    Filed: November 15, 2018
    Publication date: May 16, 2019
    Inventors: Alona TERAN, William CALLAHAN, Qahera MUNAIM, Rahul KAUSHIK